Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 692 | 552 | 1,037 | 685 | 1,975 |
| Receivables | 159 | 159 | 159 | 159 | 159 |
| TOTAL | $2,141 | $1,540 | $2,122 | $2,061 | $3,078 |
| Non-Current Assets | |||||
| PPE Net | 140 | 170 | 164 | 164 | 256 |
| Other Non-Current Assets | 2,640 | 2,673 | 2,208 | 2,044 | 740 |
| TOTAL | $2,780 | $2,843 | $2,372 | $2,208 | $995 |
| Total Assets | $4,921 | $4,383 | $4,494 | $4,269 | $4,073 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,049 | 3,590 | 3,562 | 4,490 | 4,915 |
| Accrued Expenses | 1,241 | 1,500 | 1,197 | 1,613 | 1,983 |
| TOTAL | $7,269 | $7,069 | $6,737 | $8,082 | $8,720 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,400 | 4,400 | 4,400 | 4,400 | 3,000 |
| Other Non-Current Liabilities | 1,095 | 1,149 | 1,180 | 1,272 | 73 |
| TOTAL | $7,495 | $5,549 | $5,580 | $5,672 | $3,073 |
| Total Liabilities | $14,763 | $12,618 | $12,318 | $13,754 | $11,793 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,188 | 4,164 | 3,974 | 3,934 | 3,678 |
| Common Shares | 0 | 0 | 20 | 19 | 18 |
| Retained earnings | -145,107 | -139,661 | -134,983 | -129,256 | -123,752 |
| TOTAL | $-9,842 | $-8,235 | $-7,824 | $-9,485 | $-7,720 |
| Total Liabilities And Equity | $4,921 | $4,383 | $4,494 | $4,269 | $4,073 |